TCS Agentic AI: Transforming Drug Development with AI

TCS has launched a new Agentic AI platform called TCS ADD™ AgentHub. This platform aims to transform drug development, especially in the highly regulated pharmaceutical industry. Here's the thing: The platform helps pharma companies scale AI with confidence across their R&D value chain. It's designed to manage challenges like trust, governance, and scalability when applying AI. What's interesting is that TCS ADD™ AgentHub provides a structured framework for AI agents to operate with clear roles and oversight. It also has built-in auditability. This allows companies to custom build and deploy AI agent hubs across clinical workflows. The platform offers significant benefits. Solutions powered by it have shown up to 40% efficiency gains in clinical data management. There's also up to a 30% reduction in clinical study build effort and up to 30% cost savings in safety case processing. AI-powered safety agents can even reduce quality control effort by as much as 50%. The bottom line: This platform allows a "Human + AI Operating Model" where AI agents work alongside humans, improving productivity and accelerating innovation in drug development.